Literatur
Geerts W, Cook D, Selby R et al (2002) Venous thromboembolism and its prevention in critical care. J Crit Care 17:95–104
Lilly CM, Liu X, Badawi O et al (2014) Thrombosis prophylaxis and mortality risk among critically ill adults. Chest 146:51–57
Beitland S, Sandven I, Kjaervik LK et al (2015) Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41:1209–1219
Fowler RA, Mittmann N, Geerts W et al (2014) Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA 312:2135–2145
Chan KE, Thadhani RI, Maddux FW (2013) No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. Kidney Int 84:555–561
Creekmore FM, Oderda GM, Pendleton RC et al (2006) Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism. Pharmacotherapy 26:1438–1445
Author information
Authors and Affiliations
Corresponding author
Additional information
Redaktion
S. Kluge
Rights and permissions
About this article
Cite this article
Petros, S. Thromboseprophylaxe bei kritisch Kranken. Med Klin Intensivmed Notfmed 111, 55–56 (2016). https://doi.org/10.1007/s00063-015-0087-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-015-0087-y